Free Trial

Integer (ITGR) Competitors

Integer logo
$121.00 -0.19 (-0.16%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$120.91 -0.09 (-0.07%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ITGR vs. BDSX, ELV, BAX, HOLX, MASI, GMED, TFX, ATEC, ATRC, and IART

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Biodesix (BDSX), Elevance Health (ELV), Baxter International (BAX), Hologic (HOLX), Masimo (MASI), Globus Medical (GMED), Teleflex (TFX), Alphatec (ATEC), AtriCure (ATRC), and Integra LifeSciences (IART). These companies are all part of the "medical" sector.

Integer vs. Its Competitors

Integer (NYSE:ITGR) and Biodesix (NASDAQ:BDSX) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings.

Integer presently has a consensus target price of $145.00, suggesting a potential upside of 19.83%. Biodesix has a consensus target price of $1.75, suggesting a potential upside of 534.06%. Given Biodesix's higher possible upside, analysts plainly believe Biodesix is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00
Biodesix
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.72B2.46$119.90M$2.1157.35
Biodesix$71.32M0.57-$42.93M-$0.29-0.95

99.3% of Integer shares are held by institutional investors. Comparatively, 21.0% of Biodesix shares are held by institutional investors. 2.2% of Integer shares are held by insiders. Comparatively, 30.1% of Biodesix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Integer had 4 more articles in the media than Biodesix. MarketBeat recorded 4 mentions for Integer and 0 mentions for Biodesix. Integer's average media sentiment score of 0.26 beat Biodesix's score of 0.00 indicating that Integer is being referred to more favorably in the media.

Company Overall Sentiment
Integer Neutral
Biodesix Neutral

Integer has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. Comparatively, Biodesix has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500.

Integer has a net margin of 4.38% compared to Biodesix's net margin of -54.28%. Integer's return on equity of 11.95% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer4.38% 11.95% 6.04%
Biodesix -54.28%-167.28%-39.96%

Summary

Integer beats Biodesix on 15 of the 17 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$4.22B$6.86B$5.54B$20.72B
Dividend YieldN/A1.21%5.24%3.72%
P/E Ratio57.3526.1527.4328.09
Price / Sales2.4699.70420.9838.30
Price / Cash13.5821.0936.8922.53
Price / Book2.514.748.044.58
Net Income$119.90M$173.18M$3.18B$986.06M
7 Day Performance-1.41%1.33%2.88%2.79%
1 Month Performance0.14%0.16%3.69%5.46%
1 Year Performance4.09%23.71%36.15%15.06%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
3.6218 of 5 stars
$121.00
-0.2%
$145.00
+19.8%
+5.2%$4.22B$1.72B57.3511,000
BDSX
Biodesix
3.4059 of 5 stars
$0.28
+12.7%
$1.75
+520.1%
-82.8%$36.69M$71.32M-0.97220Positive News
Gap Up
ELV
Elevance Health
4.9734 of 5 stars
$389.42
+2.1%
$498.87
+28.1%
-34.2%$86.19B$177.01B15.19104,200
BAX
Baxter International
4.3378 of 5 stars
$30.33
-0.2%
$37.25
+22.8%
-6.3%$15.60B$10.64B-27.5738,000Positive News
HOLX
Hologic
4.8581 of 5 stars
$65.16
+0.2%
$77.42
+18.8%
-11.9%$14.49B$4.03B27.497,063Positive News
MASI
Masimo
4.2191 of 5 stars
$168.22
+0.0%
$191.60
+13.9%
+46.9%$9.12B$2.09B-18.345,600
GMED
Globus Medical
4.9499 of 5 stars
$58.98
+0.6%
$94.00
+59.4%
-13.9%$7.93B$2.52B44.015,300Analyst Revision
TFX
Teleflex
4.6376 of 5 stars
$118.21
-1.1%
$164.63
+39.3%
-43.3%$5.28B$3.05B37.2914,100
ATEC
Alphatec
4.3443 of 5 stars
$11.10
+0.2%
$17.89
+61.2%
+10.1%$1.62B$611.56M-9.65700
ATRC
AtriCure
3.3192 of 5 stars
$32.77
+1.5%
$50.67
+54.6%
+41.6%$1.60B$465.31M-40.461,300Positive News
IART
Integra LifeSciences
4.0762 of 5 stars
$12.27
-0.2%
$18.63
+51.8%
-53.1%$955.08M$1.61B-32.294,396

Related Companies and Tools


This page (NYSE:ITGR) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners